Strafford
will be offering a webinar/teleconference entitled "Inducement to Infringe in Hatch-Waxman
Litigation: Lessons from Commil USA v.
Cisco Systems and Bayer Schering v.
Lupin for Pharma Patents" on August 21, 2013 from 1:00 to 2:30
pm (EDT). Thomas L. Irving, Dr. David P. Frazier, and Robert F. Shaffer of Finnegan
Henderson Farabow Garrett & Dunner will provide patent counsel with
guidance on claim and label language; to proactively coordinate patent,
regulatory and clinical personnel; and to maintain consistency between claims
and likely or actual label language throughout patent prosecution and label
negotiation with the FDA. The webinar
will review the following questions:
• What can be learned from the AstraZeneca
v. Apotex, Bayer Schering v. Lupin, and Commil USA v. Cisco
Systems Inc. decisions?
• What are the best approaches to maintain
consistency between claims and likely or actual label language?
• What steps can be taken to maintain the
coordination of patent, regulatory and clinical personnel throughout the patent
prosecution and label negotiation with the FDA?
The
registration fee for the webinar is $297 ($362 for registration and CLE processing). Those interested in registering for the
webinar, can do so here.
Comments